SCENESSE 16 mg Subcutaneous Drug Implant
RxNorm 2262259
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2262259 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SCENESSE 16 mg Subcutaneous Drug Implant.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Afamelanotide 16 mg (equivalent to 18 mg of afamelanotide acetate) Drug Implant [Scenesse]
(Atom ID: 11827623)
SBDPrescribable
Semantic Branded Drug (SBD):
Afamelanotide 16 mg Drug Implant [Scenesse]
(Atom ID: 11800931)
SYPrescribable
Synonym (SY):
Scenesse 16 mg Drug Implant
(Atom ID: 11800933)
PSNPrescribable